Both Amino- and Carboxyl-Terminal Sequences within IκBα Regulate Its Inducible Degradation
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Nuclear expression and consequent biological action of the eukaryotic NF-kappa B transcription factor complex are tightly regulated through its cytoplasmic retention by an ankyrin-rich inhibitory protein termed I kappa B alpha. I kappa B alpha specifically binds to and masks the nuclear localization signal of the RelA subunit of NF-kappa B, thereby effectively sequestering this transcription factor complex in the cytoplasm. Specific cellular activation signals lead to the rapid proteolytic degradation of I kappa B alpha and the concomitant nuclear translocation of NF-kappa B. However, the precise biochemical mechanisms underlying the inhibitory effects of I kappa B alpha on RelA and its inducible pattern of degradation remain unclear. By using HeLa cells transfected with various cDNAs end-coding epitope-tagged mutants of I kappa B alpha, our studies demonstrate the following: (i) sequences within the 72-amino-acid N-terminal region of I kappa B alpha are required for tumor necrosis factor alpha (TNF-alpha)-induced degradation but are fully dispensable for I kappa B alpha binding to and inhibition of RelA; (ii) serine residues located at positions 32 and 36 within the N-terminal region of I kappa B alpha represent major sites of induced phosphorylation (substitution of these serine residues with alanine abrogates TNF-alpha-induced degradation of I kappa B alpha); (iii) the C-terminal 40 residues of I kappa B alpha (amino acids 277 to 317), which include a PEST-like domain, are entirely dispensable for TNF-alpha-induced degradation and inhibition of RelA; (iv) a glutamine- and leucine-rich (QL) region of I kappa B alpha located between residues 263 and 277 and overlapping with the sixth ankyrin repeat is required for both inducible degradation and inhibition of RelA function; (v) regulation of I kappa B alpha degradation by this QL-rich region appears to occur independently of phosphorylation at serines 32 and 36. These findings thus indicate that I kappa B alpha is generally organized within distinct modular domains displaying different functional and regulatory properties. These studies have also led to the identification of a novel class of dominant-negative I kappa B alpha molecules that retain full inhibitory function on NF-kappa B yet fail to undergo stimulus-induced degradation. These molecules, which lack N-terminal sequences, potently inhibit TNF-alpha-induced activation of the human immune deficiency virus type 1 kappa B enhancer, thus indicating their possible use as general inhibitors of NF-kappa B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434
Cited by
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509329200 · Cited by 740
The Crystal Structure of the IκBα/NF-κB Complex Reveals Mechanisms of NF-κB Inactivation
Huxford, T., Huang, D.-B., Malek, S., & Ghosh, G. (1998) · Cell · doi:10.1016/s0092-8674(00)81699-2 · Cited by 578
The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus
Rothwarf, D. M., & Karin, M. (1999) · Science's STKE · doi:10.1126/stke.1999.5.re1 · Cited by 488
Ryals, J., Weymann, K., Lawton, K., Friedrich, L., Ellis, D., Steiner, H. Y., Johnson, J., Delaney, T. P., Jesse, T., Vos, P., et al. (1997) · The Plant Cell · doi:10.1105/tpc.9.3.425 · Cited by 480
I kappa B epsilon, a novel member of the Ikappa B family, controls RelA and cRel NF-kappa B activity
Whiteside, S. T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1413 · Cited by 395
Zamanian-Daryoush, M., Mogensen, T. H., DiDonato, J. A., & Williams, B. R. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1278-1290.2000 · Cited by 361
Xiao, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6805 · Cited by 294
Physiological functions for brain NF-κB
Meffert, M. K., & Baltimore, D. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2004.11.002 · Cited by 293
Barber, A. J., Nakamura, M., Wolpert, E. B., Reiter, C. E. N., Seigel, G. M., Antonetti, D. A., & Gardner, T. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104738200 · Cited by 288
Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation
Béraud, C., Henzel, W. J., & Baeuerle, P. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.429 · Cited by 281
Lin, X., O'Mahony, A., Mu, Y., Geleziunas, R., & Greene, W. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2933-2940.2000 · Cited by 265
Self-citationSchoonbroodt, S., Ferreira, V., Best-Belpomme, M., Boelaert, J. R., Legrand-Poels, S., Korner, M., & Piette, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4292 · Cited by 263
Emmerich, F., Meiser, M., Hummel, M., Demel, G., Foss, H.-D., Jundt, F., Mathas, S., Krappmann, D., Scheidereit, C., Stein, H., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3129 · Cited by 261
Inhibition of NF-kappa B cellular function via specific targeting of the Ikappa B-ubiquitin ligase
Yaron, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6486 · Cited by 239
“Mutation of either serine residue is sufficient to render IκB resistant to degradation (Brockman et al., 1995; Brown et al., 1995; Traenckner et al., 1995; Z.J.Chen et al., 1995; Sun et al., 1996).”
BackgroundSequential DNA damage-independent and -dependent activation of NF-kappa B by UV
Bender, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5170 · Cited by 223
“The IκBα C-terminal truncation mutants (Sun et al., 1996) pCMV-HA-IκBα (1–317), pCMV-HA-IκBα (1–263), pCMV-HA-IκBα (1–277), pCMV-HA-IκBα (1–287) and pCMV-HA-IκBα (1–297) were generously given by Dr Warner Greene (University of California, San Francisco, CA).”
BackgroundLin, X., Cunningham, E. T., Mu, Y., Geleziunas, R., & Greene, W. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80027-8 · Cited by 204
Self-citationKawamata, S., Hori, T., Imura, A., Takaori-Kondo, A., & Uchiyama, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5808 · Cited by 200
ESCRT proteins restrict constitutive NF-κB signaling by trafficking cytokine receptors
Mamińska, A., Bartosik, A., Banach-Orłowska, M., Pilecka, I., Jastrzębski, K., Zdżalik-Bielecka, D., Castanon, I., Poulain, M., Neyen, C., Wolińska-Nizioł, L., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aad0848 · Cited by 74
Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling
Dutta, K., Thammisetty, S. S., Boutej, H., Bareil, C., & Julien, J.-P. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0536-20.2020 · Cited by 55
“The human IkBa (SS32, 36AA) cDNA was amplified by PCR using the plasmid PCMV4-3HA/IkBa (SS32, 36AA) (Addgene, plasmid #24143) (Sun et al., 1996) as template.”
Method
Metadata
- Authors
- Sun, S.-C., Elwood, J., & Greene, W. C.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1996-03-01
- Volume
- 16
- Issue
- 3
- Pages
- 1058-1065
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W1866793215
- Cited by
- 149
- References
- 1
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.